Sr. Director, Cell Therapy Research

Employer
Kite Pharma
Location
Emeryville, CA, United States
Posted
Oct 06, 2020
Ref
R0015160
Hotbed
Biotech Bay
Required Education
Doctorate/PHD/MD
Position Type
Full time
Kite is continuing to hire for all open roles. Our interview process may be conducted virtually and some roles will be asked to temporarily work from home. Over the coming weeks and months, we will be implementing a phased approach to bringing employees back to site to ensure the health and safety of our teams.

For Current Kite Pharma Employees and Contractors:

Please log onto your Internal Career Site to apply for this job

Job Description

Kite, a Gilead Company, is a biopharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient's own immune system to selectively target and kill cancer cells.

Our core technology involves the genetic engineering of T cells, or white blood cells, to express either chimeric antigen receptors (CARs) or T cell receptors (TCRs) for the treatment of advanced solid and hematological malignancies.

We are on a rapid growth trajectory and have a highly energized and accomplished team.

Everyone at Kite is grounded by one common goal - curing cancer. Every single day, we seek to establish a direct line between that purpose and our day-to-day work. Does this sound exciting to you?

We are seeking an experienced scientific leader to join our team as Senior Director, Cell Therapy Research at our facility in Emeryville, California.

This position leads a group of scientists focused on multiple pipeline research programs, developing CAR-T therapy against hematological and solid malignancies. We offer a comprehensive benefits package including matching 401k, stock options, and relocation!

Responsibilities will include:
  • Responsible for overseeing multiple teams of scientists, each focused on the advancement of CAR-T therapy programs from target discovery through IND-enabling activities.
  • Lead the validation of novel targets across multiple indications, provide strategic decision making for new therapeutic programs, and ensure project timelines and goals are met.
  • Foster the development of new and existing pipeline programs in solid tumor or hematological malignancy indications, including identifying key mechanisms of therapeutic resistance in the tumor microenvironment.
  • Provide mentorship and line-function management to junior team members.


Qualifications & Experience:
  • Ph.D. in Immunology, Cell or Cancer Biology, or a related field with 12+ years of experience.
  • Prior experience in cell therapy preferred,, though a track record of success leading programs from discovery to candidate nomination in other treatment modalities such as biologics or small molecules may also be valuable.
  • Experience in oncology drug discovery, with an understanding of tumor heterogeneity and its impact on therapeutic response.
  • Expertise in assessing T cell biology and activity through typically utilized functional assays measuring cellular activation, cytokine release, proliferation, and cytotoxicity.
  • Prior experience in generating IND-enabling research and contributing to or filing IND-ready research reports.
  • Significant supervisory experience, including the management of PhD-level scientists.
  • Strong organizational as well as excellent oral and written communication skills are required to communicate project status and strategy to leadership.


*LI-SB1

#IND-123

Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

For jobs in the United States:

As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability,genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contactcareers@gilead.comfor assistance.

For more information about equal employment opportunity protections, please view the'EEO is the Law'poster.

NOTICE: EMPLOYEE POLYGRAPH PROTECTION ACT
YOUR RIGHTS UNDER THE FAMILY AND MEDICAL LEAVE ACT

PAY TRANSPARENCY NONDISCRIMINATION PROVISION

Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team.

Gilead provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion.

For Current Kite Pharma Employees and Contractors:

Please log onto your Internal Career Site to apply for this job.